
Pharmascience, a Canada-based generic pharmaceutical company, has acquired corporate venturing-backed local peer Aegera Therapeutics for an undisclosed amount.
The company issued nearly 11 million shares at $18 each compared to an expected upper range of $17 per share prior to its initial public offering. A further 1.65 million shares can be sold if demand remains strong as it began trading at $20 each.
The combined business, called Reply, estimated revenues of more than $100m next year.
IDG Ventures Boston, the corporate venturing unit of US-based publisher International Data Group before it became independent and renamed Flybridge, and venture capital firm General Catalyst Partners invested $13.75m in BzzAgent in 2006.
Pliant Technology becomes SanDisk's Enterprise Storage Solutions business.
Active Network offered 8.2 million shares in its flotation, and selling stockholders sold 2.8 million.
GE invested $55m in 12 companies in November from its $200m Ecomagination competition, including FMC-Tech.
Yandex sold more than 52 million ordinary shares at $25 each compared to a planned $22 to $24 range, for an initial market cap of about $8bn before a 55% first day pop in its share price.
In 2004, chip makers Intel and Infineon's corporate venturing fund participated in BridgeCo's $16m series C financing round, with Intel Capital having previously invested in its B round.